Tiotropium Respimat® in asthma: A double-blind, randomised, dose-ranging study in adult patients with moderate asthma

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Beeh, Kai Michael ^a   Moroni Zentgraf, Petra ^b   Ablinger, Othmar ^c   Hollaenderova, Zuzana ^d   Unseld, Anna ^b   Engel, Michael ^b   Korn, Stephanie ^e  

^a Institut fur Atemwegsforschung INSAF   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c Thalheim bei Wels ^*  (Austria)

^d BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Asthma; Bronchodilator agents; Cholinergic antagonists; Clinical trial; Respimat; Tiotropium

Indexed keywords

CORTICOSTEROID; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; SCOPOLAMINE DERIVATIVE;

ADD ON THERAPY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BODY MASS; BRONCHITIS; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DISEASE DURATION; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLUENZA; LUNG FUNCTION; LUNG FUNCTION TEST; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MODERATE PERSISTENT ASTHMA; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOPHARYNGITIS; SMOKING; SOFT MIST INHALER; THRUSH; UNSPECIFIED SIDE EFFECT; XEROSTOMIA; CONTROLLED CLINICAL TRIAL; FOLLOW UP; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PHASE 3 CLINICAL TRIAL;

ADMINISTRATION, INHALATION; ADULT; ASTHMA; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SCOPOLAMINE DERIVATIVES;

EID: 84904767957     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-15-61     Document Type: Article

References (14)

1. Global Initiative for Asthma Global strategy for asthma management and prevention. Revised 2014. [http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf], Global Initiative for Asthma.
2. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 2008, 31:320-325. 10.1183/09031936.00039707, 17959642.
3. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006, 6:13. 10.1186/1471-2466-6-13, 1483837, 16772035.
4. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004, 114:40-47. 10.1016/j.jaci.2004.04.042, 15241342.
5. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJH, Pauwels RA, Pedersen SE, . for the GOAL Investigators Group Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004, 170:836-844. 10.1164/rccm.200401-033OC, 15256389, for the GOAL Investigators Group.
6. Chowdhury BA, Dal Pan G. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med 2010, 362:1169-1171. 10.1056/NEJMp1002074, 20181964.
7. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, . for the UPLIFT Study Investigators A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554. 10.1056/NEJMoa0805800, 18836213, for the UPLIFT Study Investigators.
8. Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MPMH, Beeh KM, Rabe KF, Fabbri LM, . for the POET-COPD Investigators Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011, 364:1093-1103. 10.1056/NEJMoa1008378, 21428765, for the POET-COPD Investigators.
9. Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, Craig T, Denlinger L, Engle LL, DiMango EA, Fahy JV, Israel E, Jarjour N, Kazani SD, Kraft M, Lazarus SC, Lemanske RF, Lugogo N, Martin RJ, Meyers DA, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Wasserman SI, Walter MJ, Wechsler ME, Chinchilli VM, Bleecker ER, . for the National Heart, Lung, and Blood Institute Asthma Clinical Research Network Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010, 363:1715-1726. 10.1056/NEJMoa1008770, 3011177, 20979471, for the National Heart, Lung, and Blood Institute Asthma Clinical Research Network.
10. Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011, 128:315-322. 10.1016/j.jaci.2011.06.004, 21807250.
11. Kerstjens HAM, Disse B, Schröder-Babo W, Bantje TA, Gahlemann M, Sigmund R, Engel M, van Noord JA. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 2011, 128:308-314. 10.1016/j.jaci.2011.04.039, 21636120.
12. Kerstjens HAM, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, Sigmund R, Seibold W, Moroni-Zentgraf P, Bateman ED. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012, 367:1198-1207. 10.1056/NEJMoa1208606, 22938706.
13. Littner MR, Ilowite JS, Tashkin DP, Friedman M, Serby CW, Menjoge SS, Witek TJ. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:1136-1142. 10.1164/ajrccm.161.4.9903044, 10764302.
14. van Noord JA, Smeets JJ, Custers FLJ, Korducki L, Cornelissen PJG. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. Eur Respir J 2002, 19:639-644. 10.1183/09031936.02.00238002, 11998992.